受强制性开放获取政策约束的文章 - Kayode K. Ojo了解详情
无法在其他位置公开访问的文章：3 篇
Repurposing Infectious Disease Hits as Anti-Cryptosporidium Leads
MA Hulverson, R Choi, MC McCloskey, GR Whitman, KK Ojo, ...
ACS Infectious Diseases 7 (5), 1275-1282, 2021
强制性开放获取政策： Bill & Melinda Gates Foundation
Photoswitchable Inhibitors to Optically Control Specific Kinase Activity
T Aguirre, E Teichmann, FQ Römpp, R Vivier, C Bryant, MA Hulverson, ...
ACS chemical biology 18 (6), 1378-1387, 2023
强制性开放获取政策： US National Institutes of Health, US Department of Veterans Affairs, US …
Calcium‐Dependent Protein Kinases of Apicomplexan Parasites as Drug Targets
KK Ojo, EA Merritt, DJ Maly, WC Van Voorhis
Protein Phosphorylation in Parasites, 293-316, 2013
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：79 篇
Open source drug discovery with the malaria box compound collection for neglected diseases and beyond
WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ...
PLoS pathogens 12 (7), e1005763, 2016
强制性开放获取政策： US National Science Foundation, Bill & Melinda Gates Foundation, US National …
Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors
KK Ojo, ET Larson, KR Keyloun, LJ Castaneda, AE DeRocher, ...
Nature structural & molecular biology 17 (5), 602-607, 2010
强制性开放获取政策： US National Institutes of Health
Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii
RC Murphy, KK Ojo, ET Larson, A Castellanos-Gonzalez, BGK Perera, ...
ACS medicinal chemistry letters 1 (7), 331-335, 2010
强制性开放获取政策： US National Institutes of Health
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
B Baragaña, B Forte, R Choi, S Nakazawa Hewitt, JA Bueren-Calabuig, ...
Proceedings of the National Academy of Sciences 116 (14), 7015-7020, 2019
强制性开放获取政策： US Department of Energy, Bill & Melinda Gates Foundation, US National …
Development of Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitors with Potent Anti-Toxoplasma Activity
SM Johnson, RC Murphy, JA Geiger, AE DeRocher, Z Zhang, KK Ojo, ...
Journal of medicinal chemistry 55 (5), 2416-2426, 2012
强制性开放获取政策： US National Institutes of Health
Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors
KK Ojo, C Pfander, NR Mueller, C Burstroem, ET Larson, CM Bryan, ...
The Journal of clinical investigation 122 (6), 2301-2305, 2012
强制性开放获取政策： US National Institutes of Health
A Specific Inhibitor of PfCDPK4 Blocks Malaria Transmission: Chemical-genetic Validation
KK Ojo, RT Eastman, RSR Vidadala, Z Zhang, KL Rivas, R Choi, JD Lutz, ...
The Journal of infectious diseases 209 (2), 275-284, 2014
强制性开放获取政策： US National Institutes of Health
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with …
RSR Vidadala, KL Rivas, KK Ojo, MA Hulverson, JA Zambriski, I Bruzual, ...
Journal of medicinal chemistry 59 (13), 6531-6546, 2016
强制性开放获取政策： US Department of Energy, US National Institutes of Health, US Department of …
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis
A Castellanos-Gonzalez, AC White Jr, KK Ojo, RSR Vidadala, Z Zhang, ...
The Journal of infectious diseases 208 (8), 1342-1348, 2013
强制性开放获取政策： US National Institutes of Health
Invasion of hepatocytes by Plasmodium sporozoites requires cGMP‐dependent protein kinase and calcium dependent protein kinase 4
K Govindasamy, S Jebiwott, DK Jaijyan, A Davidow, KK Ojo, ...
Molecular microbiology 102 (2), 349-363, 2016
强制性开放获取政策： US National Science Foundation, Swiss National Science Foundation, US …
Novel bumped kinase inhibitors are safe and effective therapeutics in the calf clinical model for cryptosporidiosis
DA Schaefer, DP Betzer, KD Smith, ZG Millman, HC Michalski, ...
The Journal of infectious diseases 214 (12), 1856-1864, 2016
强制性开放获取政策： US National Institutes of Health, US Department of Agriculture
In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum
P Winzer, J Müller, A Aguado-Martínez, M Rahman, V Balmer, V Manser, ...
Antimicrobial agents and chemotherapy 59 (10), 6361-6374, 2015
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health
Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1
ET Larson, KK Ojo, RC Murphy, SM Johnson, Z Zhang, JE Kim, DJ Leibly, ...
Journal of Medicinal Chemistry 55 (6), 2803-2810, 2012
强制性开放获取政策： US National Institutes of Health
Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy
KK Ojo, MC Reid, L Kallur Siddaramaiah, J Müller, P Winzer, Z Zhang, ...
PloS one 9 (3), e92929, 2014
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health
Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection
JS Doggett, KK Ojo, E Fan, DJ Maly, WC Van Voorhis
Antimicrobial agents and chemotherapy 58 (6), 3547-3549, 2014
强制性开放获取政策： US National Institutes of Health
Development of potent and selective Plasmodium falciparum calcium-dependent protein kinase 4 (PfCDPK4) inhibitors that block the transmission of malaria to mosquitoes
RSR Vidadala, KK Ojo, SM Johnson, Z Zhang, SE Leonard, A Mitra, ...
European journal of medicinal chemistry 74, 562-573, 2014
强制性开放获取政策： US National Institutes of Health
Potent and Selective Inhibitors of CDPK1 from T. gondii and C. parvum Based on a 5-Aminopyrazole-4-carboxamide Scaffold
Z Zhang, KK Ojo, RSR Vidadala, W Huang, JA Geiger, S Scheele, R Choi, ...
ACS medicinal chemistry letters 5 (1), 40-44, 2014
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定